Shockwave Medical Inc.
NASDAQ:SWAV
| Market Cap (Intraday) | 12.41B |
| Current PE | 84.24 |
| Forward PE | 68.12 |
| 2yr Forward PE | 53.46 |
| 10-Day MA | $329.28 |
| 50-Day MA | $300.34 |
| 200-Day MA | $233.36 |
Shockwave Medical Inc. Stock, NASDAQ:SWAV
5403 Betsy Ross Drive, 5403 Betsy Ross Drive, Santa Clara, California 95054
United States of America
Phone: +1.877.775.4846
Number of Employees: 1468
Description
Shockwave Medical, Inc. operates as a medical device company, which concentrates on developing and commercializing products intended to transform the way classified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease, C2 catheters for treating coronary artery disease, and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.